1997 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of study are Internal medicine, Transplantation, Surgery, Immunology and Hematopoietic stem cell transplantation. His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology. The study incorporates disciplines such as Transplantation Conditioning, Leukemia and Clinical trial in addition to Transplantation.
His Surgery research includes themes of Incidence and Confidence interval. His Immunology course of study focuses on Stem cell and B-cell activating factor and Umbilical cord. His Hematopoietic stem cell transplantation research integrates issues from Haematopoiesis, Young adult, Adverse effect and Immune system, FOXP3.
Joseph H. Antin focuses on Internal medicine, Transplantation, Immunology, Hematopoietic stem cell transplantation and Surgery. His Internal medicine research incorporates themes from Gastroenterology and Oncology. He combines subjects such as Regimen, Total body irradiation, Cyclophosphamide, Neutrophil Engraftment and Toxicity with his study of Gastroenterology.
His study in Transplantation is interdisciplinary in nature, drawing from both Stem cell, Disease and Sirolimus. His research integrates issues of Transplantation Conditioning, Clinical trial and Complication in his study of Hematopoietic stem cell transplantation. His research links Incidence with Surgery.
His primary scientific interests are in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Gastroenterology. Internal medicine connects with themes related to Oncology in his study. Joseph H. Antin studies Transplantation, focusing on Graft-versus-host disease in particular.
He works mostly in the field of Graft-versus-host disease, limiting it down to concerns involving T cell and, occasionally, Lymphocyte. Hematopoietic stem cell transplantation is the subject of his research, which falls under Surgery. His research investigates the connection with Gastroenterology and areas like Survival rate which intersect with concerns in Natalizumab and Phases of clinical research.
Joseph H. Antin mostly deals with Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Gastroenterology and Immunology. His Internal medicine study frequently links to other fields, such as Oncology. His Transplantation study incorporates themes from Incidence, Stem cell, Hazard ratio, Leukemia and Cohort.
Surgery covers Joseph H. Antin research in Hematopoietic stem cell transplantation. His research in Gastroenterology intersects with topics in Calcineurin, Cyclophosphamide, Busulfan, Sirolimus and Confidence interval. His Immunology research is multidisciplinary, relying on both Scleroderma and Graft-versus-host disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
R H Collins;O Shpilberg;W R Drobyski;D L Porter.
Journal of Clinical Oncology (1997)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough.
The New England Journal of Medicine (2011)
Cytokine dysregulation and acute graft-versus-host disease.
J. H. Antin;J. L. M. Ferrara.
Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.
Thomas R. Ziegler;Lorraine S. Young;Kathleen Benfell;Marc Scheltinga.
Annals of Internal Medicine (1992)
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
John Koreth;Richard Schlenk;Kenneth J. Kopecky;Sumihisa Honda.
Cholecystokinin elicits the complete behavioral sequence of satiety in rats.
Joseph Antin;James Gibbs;Jonathan Holt;Robert C. Young.
Journal of Comparative and Physiological Psychology (1975)
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome
Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg.
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Richard A. Nash;Joseph H. Antin;Chatchada Karanes;Joseph W. Fay.
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
Craig Kollman;Craig W. S. Howe;Claudio Anasetti;Joseph H. Antin.
Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
David L. Porter;Mark S. Roth;Carol McGarigle;James Ferrara.
The New England Journal of Medicine (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: